CERK Gene
<div class="infobox infobox-gene">
<h3>CERK</h3>
<table>
<tr><th>Full Name</th><td>Ceramide Kinase</td></tr>
<tr><th>Gene Symbol</th><td>CERK</td></tr>
<tr><th>Chromosome</th><td>22q13.31</td></tr>
<tr><th>NCBI Gene ID</th><td>[54660](https://www.ncbi.nlm.nih.gov/gene/54660)</td></tr>
<tr><th>OMIM</th><td>[609250](https://omim.org/entry/609250)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000100324](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100324)</td></tr>
<tr><th>UniProt</th><td>[Q8TCT0](https://www.uniprot.org/uniprot/Q8TCT0)</td></tr>
<tr><th>Encoded Protein</th><td>[CERK protein](/proteins/cerk-protein)</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's disease, Stroke, Neuroinflammation, Cancer</td></tr>
</table>
</div>
Overview
CERK (Ceramide Kinase) encodes the enzyme that converts ceramide to ceramide-1-phosphate (C1P), a bioactive lipid mediator involved in cell proliferation, survival, inflammation, and membrane trafficking.[@sugiura2002] In the nervous system, CERK-C1P signaling modulates neuronal survival, microglial activation, and neuroinflammatory responses.[@olivera2013] Dysregulation of ceramide metabolism is increasingly recognized as contributing to neurodegeneration, with CERK positioned at a critical branchpoint between pro-apoptotic ceramide and pro-survival C1P signaling.
Gene Structure and Expression
The CERK gene spans approximately 82 kb on chromosome 22q13.31 and contains 11 exons.[@bornancin2002] The encoded 538-amino acid protein contains:
...
CERK Gene
<div class="infobox infobox-gene">
<h3>CERK</h3>
<table>
<tr><th>Full Name</th><td>Ceramide Kinase</td></tr>
<tr><th>Gene Symbol</th><td>CERK</td></tr>
<tr><th>Chromosome</th><td>22q13.31</td></tr>
<tr><th>NCBI Gene ID</th><td>[54660](https://www.ncbi.nlm.nih.gov/gene/54660)</td></tr>
<tr><th>OMIM</th><td>[609250](https://omim.org/entry/609250)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000100324](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100324)</td></tr>
<tr><th>UniProt</th><td>[Q8TCT0](https://www.uniprot.org/uniprot/Q8TCT0)</td></tr>
<tr><th>Encoded Protein</th><td>[CERK protein](/proteins/cerk-protein)</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's disease, Stroke, Neuroinflammation, Cancer</td></tr>
</table>
</div>
Overview
CERK (Ceramide Kinase) encodes the enzyme that converts ceramide to ceramide-1-phosphate (C1P), a bioactive lipid mediator involved in cell proliferation, survival, inflammation, and membrane trafficking.[@sugiura2002] In the nervous system, CERK-C1P signaling modulates neuronal survival, microglial activation, and neuroinflammatory responses.[@olivera2013] Dysregulation of ceramide metabolism is increasingly recognized as contributing to neurodegeneration, with CERK positioned at a critical branchpoint between pro-apoptotic ceramide and pro-survival C1P signaling.
Gene Structure and Expression
The CERK gene spans approximately 82 kb on chromosome 22q13.31 and contains 11 exons.[@bornancin2002] The encoded 538-amino acid protein contains:
- PH domain: Pleckstrin homology domain for membrane localization
- Diacylglycerol kinase domain: Catalytic domain with ATP-binding site
- C1 domain: Lipid-binding cysteine-rich region
- Calcium/calmodulin regulation: Calcium-dependent activation
Expression in the nervous system: CERK is expressed in [neurons](/entities/neurons) and glia throughout the brain, with highest expression in [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), and cerebellum.[@mitsutake2007] Expression increases in response to inflammatory stimuli and ischemic injury.
Function
Ceramide to C1P Conversion
CERK catalyzes the phosphorylation of ceramide:[@wijesinghe2005]
Substrate specificity: Prefers ceramide with C16:0, C18:0, C24:0, C24:1 acyl chains
Calcium dependence: Requires Ca2+ for optimal activity
Calmodulin binding: Ca2+/calmodulin complex activates CERK
Membrane localization: Translocates to Golgi and plasma membrane upon activationC1P Signaling Functions
Ceramide-1-phosphate mediates multiple cellular processes:[@arana2010]
Cell survival: Activates PI3K/AKT survival pathway
Proliferation: Stimulates mitogenic signaling
Inflammation: Activates cPLA2, promotes prostaglandin synthesis
Membrane trafficking: Regulates vesicle transport and exocytosis
Ion channel modulation: Affects calcium and potassium channelsNeuroinflammation
CERK-C1P in neuroinflammatory responses:[@presa2016]
- Microglial activation: C1P promotes pro-inflammatory phenotype
- Cytokine production: Enhances IL-1β, TNF-α, IL-6 release
- COX-2 induction: Increases prostaglandin E2 synthesis
- [NLRP3 inflammasome](/entities/nlrp3-inflammasome): C1P can modulate inflammasome activation
Ceramide Balance
CERK determines the ceramide/C1P balance:[@gault2018]
| Pathway | Lipid | Cellular Effect |
|---------|-------|-----------------|
| Ceramide accumulation | Ceramide | [Apoptosis](/entities/apoptosis), ER stress, [autophagy](/entities/autophagy) |
| CERK activation | C1P | Survival, proliferation, inflammation |
| Sphingomyelin hydrolysis | Ceramide | Stress response |
| C1P phosphatase | Ceramide | Reversal of C1P effects |
Disease Associations
Alzheimer's Disease
CERK and ceramide dysregulation in AD:[@filippov2012]
- Elevated ceramide: Increased ceramide levels in AD brains
- CERK downregulation: Reduced C1P production
- [Aβ](/proteins/amyloid-beta) toxicity: Aβ promotes ceramide accumulation via nSMase2
- Synaptic dysfunction: Ceramide impairs synaptic transmission
- Therapeutic potential: CERK activation may shift balance toward survival
Stroke and Ischemia
CERK in cerebral ischemia:[@novgorodov2014]
- Neuroprotection: C1P provides neuroprotection in stroke models
- Inflammation modulation: Complex effects on post-stroke inflammation
- [Blood-brain barrier](/entities/blood-brain-barrier): C1P affects BBB integrity
- Timing-dependent: Early vs late effects may differ
Neuroinflammation
CERK in inflammatory conditions:[@van2014]
- Multiple sclerosis: Altered ceramide metabolism
- Traumatic brain injury: CERK upregulation post-injury
- Infection: CERK in neurotropic viral infections
Cancer
CERK in tumor biology:[@snider2013]
- Cell survival: C1P promotes cancer cell survival
- Proliferation: Mitogenic effects on tumor cells
- Therapeutic target: CERK inhibitors in development
Expression Profile
| Tissue | Expression Level | Notes |
|--------|------------------|-------|
| Hippocampus | High | Memory circuits, vulnerable in AD |
| Cerebral cortex | High | Cognitive function |
| [Microglia](/cell-types/microglia-neuroinflammation) | High | Inflammatory mediator |
| [Astrocytes](/entities/astrocytes) | Moderate | Support cells |
| Oligodendrocytes | Moderate | Myelin maintenance |
Common Variants
| Variant | dbSNP | Effect | Clinical Relevance |
|---------|-------|--------|-------------------|
| rs2240246 | NCBI | Intronic | Stroke susceptibility |
| rs2070874 | NCBI | 3' UTR | Gene expression modifier |
| rs8137581 | NCBI | Intronic | Inflammatory response modifier |
Therapeutic Implications
CERK Modulation
Approaches targeting CERK-C1P axis:[@mikami2022]
CERK activators: Enhance C1P production for neuroprotection
CERK inhibitors: Reduce C1P in cancer and inflammation
C1P analogs: Synthetic C1P mimetics
Combination therapy: Targeting multiple nodes in sphingolipid pathwayChallenges
- Dual roles: C1P has both pro-survival and pro-inflammatory effects
- Context dependence: Effects vary by cell type and disease stage
- Ceramide balance: Must consider overall sphingolipid homeostasis
- Blood-brain barrier: Need CNS-penetrant compounds
See Also
- [CERKL Gene](/genes/cerkl)
- [Sphingolipid Metabolism](/mechanisms/sphingolipid-metabolism)
- [Neuroinflammation](/mechanisms/neuroinflammation)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Cell Death Pathways](/mechanisms/cell-death-pathways)
External Links
- [GeneCards: CERK](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CERK)
- [UniProt: Q8TCT0](https://www.uniprot.org/uniprot/Q8TCT0)
- [NCBI Gene: 54660](https://www.ncbi.nlm.nih.gov/gene/54660)
References
[Sugiura M, et al, Ceramide kinase, the enzyme producing ceramide-1-phosphate (2002)](https://pubmed.ncbi.nlm.nih.gov/12359742/)
[Olivera A, et al, Ceramide kinase and C1P in cell regulation (2013)](https://pubmed.ncbi.nlm.nih.gov/23178297/)
[Bornancin F, et al, Molecular cloning and characterization of ceramide kinase (2002)](https://pubmed.ncbi.nlm.nih.gov/11782477/)
[Mitsutake S, et al, CERK expression in brain tissues (2007)](https://pubmed.ncbi.nlm.nih.gov/17141839/)
[Wijesinghe DS, et al, Substrate specificity of ceramide kinase (2005)](https://pubmed.ncbi.nlm.nih.gov/15697813/)
[Arana L, et al, Ceramide-1-phosphate signaling in cell biology (2010)](https://pubmed.ncbi.nlm.nih.gov/21277383/)
[Presa N, et al, C1P in inflammation and immune responses (2016)](https://pubmed.ncbi.nlm.nih.gov/27079112/)
[Gault CA, et al, Ceramide and C1P balance in disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29320780/)
[Filippov V, et al, Ceramide metabolism in Alzheimer's disease (2012)](https://pubmed.ncbi.nlm.nih.gov/22458779/)
[Novgorodov SA, et al, C1P and neuroprotection in stroke (2014)](https://pubmed.ncbi.nlm.nih.gov/23686689/)
[Van Echten-Deckert G, et al, Sphingolipids in neuroinflammation (2014)](https://pubmed.ncbi.nlm.nih.gov/24607829/)
[Snider AJ, et al, CERK in cancer biology (2013)](https://pubmed.ncbi.nlm.nih.gov/23583717/)
[Mikami D, et al, Therapeutic targeting of ceramide kinase (2022)](https://pubmed.ncbi.nlm.nih.gov/35657932/)